Squamous cell carcinoma of the skin: Emerging need for novel biomarkers

doi:10.5306/wjco.v4.i4.85

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7614)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

478

HTML

4844

Figures (1-1)

271

Tables (1-2)

227

Sum=5820

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

952

Download

842

Sum=1794

Nov 10, 2013 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Oncol. Nov 10, 2013; 4(4): 85-90
Published online Nov 10, 2013. doi: 10.5306/wjco.v4.i4.85

Open in New Tab Full Size Figure Download Figure

Figure 1 Pathways involved in the pathogenesis of cutaneous squamous cell carcinoma. Originated from Madan et al[2], with permission. p53: Tumor protein 53; CDKN2A: Cyclin-dependent kinase inhibitor 2A; MC1R: Melanocortin 1 receptor; XPC: Xeroderma pigmentosum complementation group C.

Citation: Kivisaari A, Kähäri VM. Squamous cell carcinoma of the skin: Emerging need for novel biomarkers. World J Clin Oncol 2013; 4(4): 85-90
URL: https://www.wjgnet.com/2218-4333/full/v4/i4/85.htm
DOI: https://dx.doi.org/10.5306/wjco.v4.i4.85